Pauline Roche
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impact of CDA Dynamics on Clinical Outcome of Patients With AML or High-Risk MDS Treated With Nucleoside Analogs.
Journal: Hematological oncology
Published: December 23, 2024
Predicting the toxicity-efficacy ratio of venetoclax in real-world patients.
Journal: Annals of hematology
Published: December 09, 2024
Body mass index affects imatinib exposure: Real-world evidence from TDM with adaptive dosing.
Journal: Fundamental & clinical pharmacology
Published: July 24, 2024
Therapy-related myeloid neoplasms after 177Lu-DOTATATE therapy for metastatic neuroendocrine neoplasia: CPX-351 consolidated by allogeneic stem cells transplantation as applicable therapeutic strategy.
Journal: Leukemia & lymphoma
Published: April 12, 2023
Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm.
Journal: Cells
Published: November 08, 2022
Could daratumumab induce the maturation of plasmablasts in Plasmablastic lymphoma?-Potential therapeutic applications.
Journal: European journal of haematology
Published: November 13, 2020
Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone.
Journal: European journal of haematology
Published: June 06, 2019
Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients.
Journal: European journal of internal medicine
Published: April 01, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026